DE602005019556D1 - Polycyclische pyrazine als kaliumionenkanal-modulatoren - Google Patents
Polycyclische pyrazine als kaliumionenkanal-modulatorenInfo
- Publication number
- DE602005019556D1 DE602005019556D1 DE602005019556T DE602005019556T DE602005019556D1 DE 602005019556 D1 DE602005019556 D1 DE 602005019556D1 DE 602005019556 T DE602005019556 T DE 602005019556T DE 602005019556 T DE602005019556 T DE 602005019556T DE 602005019556 D1 DE602005019556 D1 DE 602005019556D1
- Authority
- DE
- Germany
- Prior art keywords
- polycyclic
- kaliumion
- pyrazins
- channel modulators
- unsubstituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- -1 polycyclic pyrazines Chemical class 0.000 abstract 2
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 abstract 1
- 125000006582 (C5-C6) heterocycloalkyl group Chemical group 0.000 abstract 1
- 102000004257 Potassium Channel Human genes 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000002405 diagnostic procedure Methods 0.000 abstract 1
- 108020001213 potassium channel Proteins 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Amplifiers (AREA)
- Discharge Lamp (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US56214904P | 2004-04-13 | 2004-04-13 | |
| PCT/US2005/012525 WO2005121126A1 (en) | 2004-04-13 | 2005-04-13 | Polycyclic pyrazines as potassium ion channel modulators |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602005019556D1 true DE602005019556D1 (de) | 2010-04-08 |
Family
ID=35079213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602005019556T Active DE602005019556D1 (de) | 2004-04-13 | 2005-04-13 | Polycyclische pyrazine als kaliumionenkanal-modulatoren |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7642354B2 (de) |
| EP (1) | EP1742935B1 (de) |
| AT (1) | ATE458730T1 (de) |
| AU (1) | AU2005252160A1 (de) |
| CA (1) | CA2561831A1 (de) |
| DE (1) | DE602005019556D1 (de) |
| WO (1) | WO2005121126A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2599544A1 (en) * | 2005-02-28 | 2006-09-08 | Japan Tobacco Inc. | Novel aminopyridine compound with syk inhibitory activity |
| WO2007042571A1 (en) * | 2005-10-14 | 2007-04-19 | Neurosearch A/S | Novel pyrimidine-2,4-diamine derivatives and their use as modulators of small-conductance calcium-activated potassium channels |
| DE602007006643D1 (de) * | 2006-03-17 | 2010-07-01 | Univ Liege | Bis-1,2,3,4-tetrahydroisochinolinderivate und ihre verwendung als pharmazeutika |
| US9216963B2 (en) * | 2006-06-22 | 2015-12-22 | Medibeacon Inc. | Pyrazine derivatives with extended conjugation and methods of using the same in optical applications |
| WO2009037247A1 (en) * | 2007-09-17 | 2009-03-26 | Neurosearch A/S | Pyrazine derivatives and their use as potassium channel modulators |
| EP3078662A1 (de) | 2007-09-21 | 2016-10-12 | Array Biopharma, Inc. | Pyridin-2-yl-amino-1,2,4-thiadiazol derivate als glucokinase aktivatoren zur behandlung von diabetes mellitus |
| GB0719644D0 (en) | 2007-10-05 | 2007-11-14 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| FR2925906B1 (fr) * | 2008-01-02 | 2010-08-20 | Sanofi Aventis | COMPOSES DE N-PHENYL-IMIDAZO°1,2-a!PYRIDINE-2-CARBOXAMIDES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE |
| US20090270418A1 (en) * | 2008-01-09 | 2009-10-29 | Marianne Sloss | Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith |
| SI2252597T1 (sl) * | 2008-02-01 | 2014-07-31 | Akinion Pharmaceuticals Ab | Derivati pirazina in njihova uporaba kot inhibitorji protein kinaze |
| GB0803018D0 (en) | 2008-02-19 | 2008-03-26 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
| WO2009119528A1 (ja) * | 2008-03-24 | 2009-10-01 | 武田薬品工業株式会社 | 複素環化合物 |
| GB0821307D0 (en) * | 2008-11-21 | 2008-12-31 | Summit Corp Plc | Compounds for treatment of duchenne muscular dystrophy |
| CA2849566C (en) | 2011-11-09 | 2021-02-09 | Cancer Research Technology Limited | 5-(pyridin-2-yl-amino)-pyrazine-2-carbonitrile compounds and their therapeutic use |
| IN2014DN09221A (de) | 2012-05-15 | 2015-07-10 | Cancer Rec Tech Ltd | |
| RU2644769C2 (ru) | 2013-01-23 | 2018-02-14 | Астразенека Аб | Химические соединения |
| AU2015218402B2 (en) | 2014-02-14 | 2019-07-11 | Takeda Pharmaceutical Company Limited | Pyrazines modulators of GPR6 |
| US9775839B2 (en) | 2014-03-13 | 2017-10-03 | Merck Sharp & Dohme Corp. | 2-pyrazine carboxamides as spleen tyrosine kinase inhibitors |
| CN108690006B (zh) * | 2017-04-12 | 2022-02-18 | 中国药科大学 | 一类化合物及其在抗aml药物中的用途 |
| TW202317106A (zh) | 2021-08-27 | 2023-05-01 | 南韓商柳韓洋行 | 作為egfr抑制劑之取代胺基吡啶化合物 |
| TW202317105A (zh) * | 2021-08-27 | 2023-05-01 | 南韓商柳韓洋行 | 作為egfr抑制劑之含六員雜芳基之胺基吡啶化合物 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8504631D0 (en) | 1985-02-22 | 1985-03-27 | Ici Plc | Chromogenic compounds |
| US20040102455A1 (en) | 2001-01-30 | 2004-05-27 | Burns Christopher John | Method of inhibiting kinases |
| US6593349B2 (en) | 2001-03-19 | 2003-07-15 | Icagen, Inc. | Bisarylamines as potassium channel openers |
| GB0108102D0 (en) | 2001-03-30 | 2001-05-23 | Pfizer Ltd | Compounds |
| JP2005530763A (ja) | 2002-05-13 | 2005-10-13 | アイシーエージェン，インコーポレイティド | カリウム・チャネル調節物質としてのビス−ベンズイミダゾール及び関連化合物 |
| GB0215775D0 (en) | 2002-07-06 | 2002-08-14 | Astex Technology Ltd | Pharmaceutical compounds |
| EP1606266A4 (de) | 2003-03-21 | 2008-06-25 | Smithkline Beecham Corp | Chemische verbindungen |
| GB2400101A (en) * | 2003-03-28 | 2004-10-06 | Biofocus Discovery Ltd | Compounds capable of binding to the active site of protein kinases |
| EP1678160A1 (de) | 2003-10-27 | 2006-07-12 | Astellas Pharma Inc. | Pyrazinderivate und deren pharmazeutische verwendung |
| PT1689739T (pt) | 2003-12-03 | 2016-07-13 | Ym Biosciences Australia Pty | Inibidores de cinases baseados em azol |
| WO2005058876A1 (en) | 2003-12-16 | 2005-06-30 | Gpc Biotech Ag | Pyrazine derivatives as effective compounds against infectious diseases |
| GB2424882B (en) | 2004-01-12 | 2008-08-06 | Cytopia Res Pty Ltd | Selective kinase inhibitors |
-
2005
- 2005-04-13 DE DE602005019556T patent/DE602005019556D1/de active Active
- 2005-04-13 EP EP05779464A patent/EP1742935B1/de not_active Not-in-force
- 2005-04-13 WO PCT/US2005/012525 patent/WO2005121126A1/en active Application Filing
- 2005-04-13 CA CA002561831A patent/CA2561831A1/en not_active Abandoned
- 2005-04-13 US US11/105,668 patent/US7642354B2/en not_active Expired - Fee Related
- 2005-04-13 AU AU2005252160A patent/AU2005252160A1/en not_active Abandoned
- 2005-04-13 AT AT05779464T patent/ATE458730T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE458730T1 (de) | 2010-03-15 |
| AU2005252160A1 (en) | 2005-12-22 |
| CA2561831A1 (en) | 2005-12-22 |
| WO2005121126A1 (en) | 2005-12-22 |
| US20050239800A1 (en) | 2005-10-27 |
| EP1742935A1 (de) | 2007-01-17 |
| US7642354B2 (en) | 2010-01-05 |
| EP1742935B1 (de) | 2010-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE458730T1 (de) | Polycyclische pyrazine als kaliumionenkanal- modulatoren | |
| AR045595A1 (es) | Composiciones utiles como inhibidores de proteinas quinasas | |
| BRPI0510177B8 (pt) | composto, composição farmacêutica e uso do mesmo | |
| BRPI0407827A (pt) | compostos de aminoeteroarila como inibidores de proteìna cinase | |
| NO20066015L (no) | Fuserte heterosykliske forbindelser | |
| NO20050418L (no) | Kondenserte pyridiner og pyrimidiner med TIE2(TEK) aktivitet | |
| CY1116272T1 (el) | Φαρμακευτικα σκευασματα που περιεχουν μεθυλναλτρεξονη | |
| DE602004025803D1 (de) | Verwendung von kondensierten heterozyklischen verbindungen als scce-hemmern zur behandlung von hautzuständen | |
| TR201906416T4 (tr) | Hiv inhibitörü bileşiklerin fosfonat analogları. | |
| NO20063821L (no) | Kinolinderivater for anvendelse som mykobakterielle inhibitorer | |
| PE20061436A1 (es) | Derivados de amida sustituida como inhibidores de proteina quinasa | |
| CA2492096A1 (en) | Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides | |
| EA200800886A1 (ru) | Способ получения 1-н-имидазо[4,5-с]пиридинов и их аналогов | |
| HU0302788D0 (en) | New compounds | |
| EA201000149A1 (ru) | Производные 1-фенил-2-пиридинилалкиловых спиртов в качестве ингибиторов фосфодиэстераз | |
| DE602006015215D1 (de) | Prolinamidderivate als natriumkanalmodulatoren | |
| IL192253A0 (en) | Substituted cyclohexylmethyl derivatives | |
| ATE338461T1 (de) | Pyrazolpyrimidinfungizide | |
| ES2328496T3 (es) | Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos. | |
| DE60316984D1 (de) | Benzoylsulfonamide als antitumor-mittel | |
| DE602004031410D1 (de) | Inden derivate als pharmazeutika | |
| DE602004029355D1 (de) | Sulfopyrrolderivate | |
| ATE485822T1 (de) | Phenylaminopyridine und phenylaminopyrazine | |
| HUP0301587A2 (hu) | Foszfodiészteráz V gátló hatású 5-amino-alkil-pirazolo[4,3-d]pirimidinek, ezeket tartalmazó gyógyszerkészítmények és eljárások az elżállításaikra | |
| EA200600100A1 (ru) | Производные никотинамида, полезные в качестве ингибиторов pde4 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition |